Recent Finacing
Recent Raise
Accure Therapeutics is a Barcelona neuroscience R&D firm developing PREP inhibitor ACT-02 for Parkinson’s with ACT-01/03 programs, using a lean pharma model integrating acquired assets for preclinical-to-IND development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Accure Therapeutics.
